SCHEMBL3707615

SCHEMBL3707615

CCC(C)(C)c1ncc[nH]1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP19A1 P11511 3/20 0.38
TXN P10599 1/20 0.34
TXNRD1 Q16881 1/20 0.34
TAAR1 Q96RJ0 5/20 0.33
HTR1A P08908 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
ALOX15 P16050 1/20 0.31
NISCH Q9Y2I1 1/20 0.31
FDPS P14324 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3700407 0.83 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2CYP19A1TXNTXNRD1
SCHEMBL13493243 0.83 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2CYP19A1TXNTXNRD1
SCHEMBL9459967 0.81 CYP19A1 (0.41) ALDH1A1SMN1; SMN2CYP19A1TXNTXNRD1
SCHEMBL3695170 0.80 CYP19A1 (0.39) ALDH1A1SMN1; SMN2CYP19A1TXNTXNRD1
SCHEMBL29749649 0.80 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2CYP19A1TXNTXNRD1
SCHEMBL27922362 0.79 CYP19A1 (0.38) ALDH1A1SMN1; SMN2CYP19A1TXNTXNRD1
SCHEMBL5500827 0.78 CYP19A1 (0.39) ALDH1A1SMN1; SMN2CYP19A1FDPS
SCHEMBL22059382 0.77 CYP19A1 (0.37) ALDH1A1SMN1; SMN2CYP19A1CYP1A2CYP3A4
SCHEMBL27951250 0.77 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2CYP19A1TXNTXNRD1
SCHEMBL67017 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103361630-A Group 2 imidazolate formulations for direct liquid injection AIR PROD & CHEM 2013-10-23 CN claimed
WO-2022007966-A1 PB2 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川海思科制药有限公司 2022-01-13 WO disclosed
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof SHANGHAI HAIHE PHARMACEUTICAL CO., LTD. (CN) 2021-04-06 US disclosed
US-9884828-B2 Substituted cinnolines as inhibitors of LRRK2 kinase activity IMAGO PHARMACEUTICALS, INC. (US) 2018-02-06 US disclosed
US-9873680-B2 Therapeutic compounds GILEAD SCIENCES, INC. (US) 2018-01-23 US disclosed
WO-2016033243-A9 ANTIRETROVIRAL AGENTS GILEAD SCIENCES, INC. (US) 2016-05-19 WO disclosed
US-9018387-B2 Complexes of imidazole ligands AIR PRODUCTS AND CHEMICALS, INC. (US) 2015-04-28 US disclosed
US-8680289-B2 Complexes of imidazole ligands AIR PRODUCTS AND CHEMICALS, INC. (US) 2014-03-25 US disclosed
CN-103361630-A Group 2 imidazolate formulations for direct liquid injection AIR PROD & CHEM 2013-10-23 CN disclosed
EP-2580223-A1 COMPLEXES OF IMIDAZOLE LIGANDS Air Products and Chemicals, Inc. (US) 2013-04-17 EP disclosed
US-20130078391-A1 Complexes Of Imidazole Ligands AIR PRODUCTS AND CHEMICALS, INC. (US) 2013-03-28 US disclosed
US-20120276051-A1 INHIBITORS OF HEPATITIS C VIRUS PRESIDIO PHARMACEUTICALS, INC. (US) 2012-11-01 US disclosed
US-20120121806-A1 Complexes Of Imidazole Ligands AIR PRODUCTS AND CHEMICALS, INC. (US) 2012-05-17 US disclosed
CN-102344413-A Volatile imidazoles and group 2 imidazole based metal precursors AIR PROD & CHEM 2012-02-08 CN disclosed
WO-2011156699-A1 COMPLEXES OF IMIDAZOLE LIGANDS AIR PRODUCTS AND CHEMICALS, INC. (US) 2011-12-15 WO disclosed
WO-2008116339-A2 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120276051-A1 INHIBITORS OF HEPATITIS C VIRUS HAVCR2, LIPC, HCCS ALDH1A1 1654/4885SMN1; SMN2 4681/4885CYP19A1 3232/4885
US-20130078391-A1 Complexes Of Imidazole Ligands ICOSLG, CLTC, PICALM ALDH1A1 4464/4885SMN1; SMN2 4415/4885CYP19A1 4833/4885
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof EZH2, IKZF2, SUZ12 ALDH1A1 2816/4885SMN1; SMN2 4308/4885CYP19A1 937/4885
US-20120121806-A1 Complexes Of Imidazole Ligands ICOSLG, CLTC, PICALM ALDH1A1 4464/4885SMN1; SMN2 4415/4885CYP19A1 4833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.